The world infusion pumps market will reach $7.74bn in 2014, Says the New Study on ASDReports

Friday 12 December 2014, Amsterdam

The new report now available on ASDReports, predicts that the world market for infusion pumps will reach $7.74bn in 2014. This forecast and others appear in Infusion Pumps Market Forecast 2014-2024: Prospects for Leading Companies, published in October 2014.

The report predicts that the infusion pumps market will grow steadily to 2024. The market for infusion pumps is mature, but some growth areas remain, particularly in key markets where insulin pumps are set to expand. The future of the infusion pumps market appears promising. There is significant potential for growth and investment, driven by global increasing patient demographics, a growing homecare market in developed countries and improving healthcare reimbursement in developing countries.

The infusion pumps market is diverse in its technologies and its geographic distribution. The market is intensely competitive, with industry leaders retaining market share through continuous product innovation and aggressive pricing, while smaller players resort to product building in a bid to sustain revenues. Despite the market being dominated by a few large manufacturers, there are many small companies manufacturing niche and innovative products. Each company has employed unique market and positioning strategies in an effort to increase their market share in the global market.

Wenlu Hu, a pharmaceutical and medical devices industry analyst at visiongain, said: “Successful harnessing of the opportunities for growth in the infusion pumps market from 2014 to 2024 will depend upon the development of new smart pumps with technologies that increase cost effectiveness and comply with the FDA’s safety regulations. Products based on superior technology, particularly those technologies that increase safety, patient compliance and convenience of usage, are more likely to succeed.”

“In the future, manufacturers will mainly be looking for ways to improve their profitability through infusion pumps. This could happen via emerging economies such as China, India, and Brazil that present ample growth opportunities. Since the profit margin per product in the infusion pumps market is relatively low, manufacturers will need to find ways to achieve high-volume product sales.”

The  brand new 216-page report provides revenue forecasts to 2024 for the world infusion pumps market and leading submarkets. It forecasts sales for the insulin pumps, enteral feeding and other infusion pumps (including chemotherapy pumps and PCA pumps) segments of the market from 2014 to 2024.

Additionally, the report provides revenue forecasts for 12 leading national infusion pumps markets including US, China, Japan, Germany, France, UK, Italy, Spain, Russia, India, Brazil, South Korea and Rest of the World from 2014 to 2024.

The report also profiles 32 leading products in the infusion pumps market manufactured by companies including - Animas (Johnson & Johnson), Hospira, CareFusion, Baxter, Roche, B. Braun, Fresenius, and Smiths Medical. Moreover, the report forecasts the competing drug technologies market from 2014 to 2024.

It also discusses products in the development pipeline, commercial news, drivers and restraints in each country and submarkets, as well as qualitative SWOT and Porter’s Five Forces analysis to understand the competitive landscape within this market. The report also includes an exclusive interview with an industry expert regarding current market trends, particularly the challenges of entering emerging markets.

Infusion Pumps Market Forecast 2014-2024: Prospects for Leading Companies adds to visiongain’s range of analytical reports on industries and markets in healthcare.